AC REMOVAL MECHANISM

Molecular and cellular mechanisms in phagocytosis of apoptotic cells

 Coordinatore TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY 

 Organization address address: TECHNION CITY - SENATE BUILDING
city: HAIFA
postcode: 32000

contact info
Titolo: Mr.
Nome: Mark
Cognome: Davison
Email: send email
Telefono: +972 4 829 4854
Fax: +972 4 823 2958

 Nazionalità Coordinatore Israel [IL]
 Totale costo 100˙000 €
 EC contributo 100˙000 €
 Programma FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013)
 Code Call FP7-PEOPLE-2009-RG
 Funding Scheme MC-IRG
 Anno di inizio 2009
 Periodo (anno-mese-giorno) 2009-11-01   -   2013-10-31

 Partecipanti

# participant  country  role  EC contrib. [€] 
1    TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY

 Organization address address: TECHNION CITY - SENATE BUILDING
city: HAIFA
postcode: 32000

contact info
Titolo: Mr.
Nome: Mark
Cognome: Davison
Email: send email
Telefono: +972 4 829 4854
Fax: +972 4 823 2958

IL (HAIFA) coordinator 100˙000.00

Mappa


 Word cloud

Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.

pathways    removal    human    mechanisms    aberrant    phagocytes    glia    simu    diseases    interaction    ac    homeostasis    surface    nervous    inflammation    tissue    recognition    receptor    mechanism    apoptotic    unwanted    medical    additional    phagocytic    molecular    function    cellular    cells    macrophages    clearance    microns    treatment    binding    biological    previously    signaling    action    recognise    ligand    drosophila    cell    proper    diagnosis    elimination    molecules    subsequent    engulfment    six    phagocytosis    receptors    apoptosis   

 Obiettivo del progetto (Objective)

'The proper elimination of unwanted or aberrant cells through apoptosis and subsequent phagocytosis plays a crucial role in metazoan development and tissue homeostasis. Inefficient or defective removal of apoptotic cells leads to inflammation and autoimmune diseases. Given that in vertebrates phagocytosis is a complex and highly redundant process, we are using the Drosophila model, which permits comprehensive in vivo studies and provides complement to medical and applied approaches in the field. We previously identified and characterized a novel phagocytic receptor, named Six Microns Under (Simu), which strongly binds to apoptotic cells and is required for their recognition and engulfment by glia in the nervous system and by macrophages elsewhere. However, the mode of SIMU’s action is, like of many other phagocytic receptors, still unknown. The goal of the proposed research is to elucidate the molecular and cellular mechanisms underlying the recognition of apoptotic cells by phagocytes and subsequent signaling for engulfment. We will further characterize SIMU’s function by finding its physical interaction partners, both its ligand on the apoptotic cell and its presumptive co-receptor on the phagocyte. Then we will focus on the mechanisms of their action and interaction. Based on two independent genetic screens we will test candidates with presumed or known function in phagocytosis in order to explore novel pathways in apoptotic cell clearance. By studying factors involved in different pathways we will address the redundancy issue in the phagocytosis process. Accomplishment of our research goal will shed light on the general mechanisms of receptor binding, clustering and signaling in phagocytosis, which will provide novel and important insight into a key biological process with potential translation into equivalent studies in mammalian systems and medical applications in the diagnosis and treatment of human diseases.'

Introduzione (Teaser)

A European study worked on elucidating how phagocytes recognise apoptotic cells. Given the importance of this process in biology, the study findings have significant medical implications.

Descrizione progetto (Article)

Proper development and tissue homeostasis is highly dependent on the elimination of unwanted or aberrant cells. This is achieved through apoptosis and subsequent phagocytosis of dead cells. Failure to do so could lead to inflammation and autoimmunity.

The EU-funded 'Molecular and cellular mechanisms in phagocytosis of apoptotic cells' (AC REMOVAL MECHANISM) project investigated the molecular and cellular mechanisms associated with phagocytic recognition of apoptotic cells. The work concentrated on the previously identified Six Microns Under (SIMU) receptor. Through SIMU, macrophages and glia in the nervous system recognise and engulf apoptotic cells.

To understand how SIMU functions, researchers looked for its associating partner molecules. In this context, they characterised which SIMU domains were responsible for binding to apoptotic cells and the phagocytic surface. They identified phospholipid phosphatidylserine as a SIMU ligand on the surface of apoptotic cells. Findings revealed that additional caspase ligands were required for efficient clearance of apoptotic cells.

These findings were corroborated through experiments in Drosophila embryos clearly illustrating that additional mechanisms to SIMU signalling are in place for phagocytosis of unwanted cells. Scientists investigated the role of additional receptors (LDL and CD36) by generating flies lacking these molecules. This helped in understanding the process of apoptotic cell clearance during Drosophila embryogenesis.

Collectively, the AC REMOVAL MECHANISM study provided the basis for identifying novel actors implicated in the process of phagocytic clearance of apoptotic cells. Apart from fundamental insight into the key biological process of phagocytosis, the project findings have potential applications in the diagnosis and treatment of human diseases.

Altri progetti dello stesso programma (FP7-PEOPLE)

FISH (2014)

Fish Indicatiors of Stress and Health (FISH): Validating the use of embryos and yolk sac larval zebrafish as a model for the study of nociception and veterinary drug testing

Read More  

HM-PP (2010)

Advances in Horizontal Merger Policy and Selected Public Policy Topics

Read More  

ECCFP (2012)

Enabling Cost-effective Process Simulation for the Composites Industry: Efficient Characterisation of Complex Fibre Preforms

Read More